Dechra Pharmaceuticals PLC — Director's Dealing 2016

Mar 21, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7837S

Dechra Pharmaceuticals PLC

21 March 2016

21 March 2016

Dechra® Pharmaceuticals PLC

(Dechra or the Company) 

Director / PDMR Shareholding

Dechra Pharmaceuticals PLC has been notified that today, 21 March 2016,

Anne-Francoise Nesmes, Chief Financial Officer,  and her spouse, Jeramy Rankine, both sold 1,550 shares each at £12.08 per share.

Following the sale, Anne-Francoise Nesmes's beneficial interest in the Company is 39,502 shares, which represents 0.043% of the current issued share capital.

Suzana Cross, General Counsel and Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSAKDDDQBKDANB